Find your next M&A target
Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.
Project details
Japanese non-intrusive blood glucose testing company seeks financing.
| Project region | Japan |
|---|---|
| Industry | Healthcare |
| Total value of the target | N/A |
| Expected target net rate of return after deducting all taxes and fees | N/A |
| Validity period of pending order | 365 |
CONTACT ADVISOR
Simon Laube
Assistant Manager, International Business Advisory
| Project highlights | intelligent wearable devices - received USD 10 million |
|---|---|
| Project description |
The Japanese company focuses on the development of intelligent wearable devices. Its non-intrusive blood glucose monitoring technology can avoid the harm to the body caused by the traditional blood glucose detection method while achieving the same detection effect as the traditional detection method. The core team members come from famous companies such as Sony, Toshiba, Dentsu and Toyota Tsusho Systems, and have rich experience in enterprise management and software and hardware development of electronic products. Since its establishment, the company has received USD 10 million from Taisho Pharmaceutical Group, Tomita and Alfresa Holdings. Now the company seeks financing. |
Enquire for more information about our services, and how we can help solve challenges for your organization
Contact Us